How to Use a Noninferiority Trial: Users' Guides to the Medical Literature
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Clinical investigators are increasingly testing treatments that have the primary benefit of decreased burden or harms relative to an existing standard. The goal of the resulting randomized trials--called noninferiority trials--is to establish that the novel treatment's effectiveness is not substantially less than the existing standard. Conclusions from these trials are, however, based on noninferiority thresholds specified by authors whose judgments may not coincide with those of patients and clinicians. This article highlights issues related to validity, interpretation, and applicability of results specific to noninferiority trials. Suboptimal administration of standard treatment or exclusive reliance on the analyze-as-randomized approach that is standard for conventional superiority trials may produce misleading results in noninferiority trials. Clinicians should judge whether the novel treatment's impact on effectiveness outcomes--the prime reason for wanting to prescribe it--is sufficiently close to that of standard treatment that they are comfortable substituting it for the existing standard. Trading off desirable and undesirable consequences is an individual decision: given the benefits of a novel treatment, some patients may perceive the uncertainty regarding a reduction in treatment effectiveness as acceptable while others may not.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428
The Intention-to-Treat Principle: How to Assess the True Effect of Choosing a Medical Treatment
Detry, M. A., & Lewis, R. J. (2014) · JAMA · doi:10.1001/jama.2014.7523 · Cited by 634
Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials
Kaul, S., & Diamond, G. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00011 · Cited by 272 · cited 1×
“reasoning and clinical judgment in determining noninferiority thresholds.(2,3) What is sound reasoning for one observer, how-”
Quality of Reporting of Noninferiority and Equivalence Randomized Trials
Le Henanff, A., Giraudeau, B., Baron, G., & Ravaud, P. (2006) · JAMA · doi:10.1001/jama.295.10.1147 · Cited by 263
Yank, V., Rennie, D., & Bero, L. A. (2007) · BMJ · doi:10.1136/bmj.39376.447211.be · Cited by 235 · cited 1×
“Unfortunately, editors are not always thorough in carrying out due diligence in this aspect (and others) of reporting.(18)”
Lessons From and Cautions About Noninferiority and Equivalence Randomized Trials
Gøtzsche, P. C. (2006) · JAMA · doi:10.1001/jama.295.10.1172 · Cited by 106
Cited by
The placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
The Intention-to-Treat Principle: How to Assess the True Effect of Choosing a Medical Treatment
Detry, M. A., & Lewis, R. J. (2014) · JAMA · doi:10.1001/jama.2014.7523 · Cited by 634
Ducrocq, G., Gonzalez-Juanatey, J. R., Puymirat, E., Lemesle, G., Cachanado, M., Durand-Zaleski, I., Arnaiz, J. A., Martínez-Sellés, M., Silvain, J., Ariza-Solé, A., et al. (2021) · JAMA · doi:10.1001/jama.2021.0135 · Cited by 290
Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections
The BALANCE Investigators (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2404991 · Cited by 158
Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial
Courtney, R. J., McRobbie, H., Tutka, P., Weaver, N. A., Petrie, D., Mendelsohn, C. P., Shakeshaft, A., Talukder, S., Macdonald, C., Thomas, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.7621 · Cited by 118
Metadata
- Authors
- Mulla, S. M., Scott, I. A., Jackevicius, C. A., You, J. J., & Guyatt, G. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-12-26
- Volume
- 308
- Issue
- 24
- Pages
- 2605
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2146785136
- Cited by
- 96
- References
- 8
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.